B6;129S5-Il25tm1Lex/Orl

Status

Available to order

EMMA IDEM:02348
International strain nameB6;129S5-Il25tm1Lex/Orl
Alternative nameLEXKO-0310
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolIl25tm1Lex
Gene/Transgene symbolIl25

Information from provider

Provider Lexicon Genetics, Inc.
Provider affiliationLexicon Pharmaceuticals
Phenotypic informationThe male homozygous mutant mice exhibited notably increased mean serum triglyceride levels when compared with their gender-matched wild-type littermates and the historical mean. No other notable phenotype was observed for the homozygous mutant mice.
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France

Disease and phenotype information

IMPC phenotypes (gene matching)
  • enlarged testis / IMPC
  • abnormal testis morphology / IMPC
  • abnormal eye morphology / IMPC
  • microphthalmia / IMPC
  • cataract / IMPC
  • prolonged QRS complex duration / IMPC
  • abnormal vitreous body morphology / IMPC
  • small testis / IMPC
MGI phenotypes (allele matching)
  • increased circulating triglyceride level / MGI
MGI phenotypes (gene matching)
  • abnormal crypts of Lieberkuhn morphology / MGI
  • abnormal colon morphology / MGI
  • increased circulating triglyceride level / MGI
  • intestinal inflammation / MGI
  • lung inflammation / MGI
  • decreased susceptibility to bacterial infection / MGI
  • increased IgE level / MGI
  • no phenotypic analysis / MGI
  • abnormal intestinal goblet cell morphology / MGI
  • increased susceptibility to experimental autoimmune encephalomyelitis / MGI
  • decreased eosinophil cell number / MGI
  • increased T cell number / MGI
  • abnormal response to infection / MGI
  • increased susceptibility to parasitic infection / MGI
  • abnormal mesenteric lymph node morphology / MGI
  • increased susceptibility to type I hypersensitivity reaction / MGI
  • decreased T-helper 2 cell number / MGI
  • decreased IgG2a level / MGI
  • decreased susceptibility to induced colitis / MGI
  • decreased tumor necrosis factor secretion / MGI
  • abnormal interleukin secretion / MGI
  • decreased interleukin-1 beta secretion / MGI
  • decreased interleukin-13 secretion / MGI
  • decreased interleukin-4 secretion / MGI
  • decreased interleukin-5 secretion / MGI
  • decreased interleukin-9 secretion / MGI
  • abnormal chemokine secretion / MGI
  • abnormal interferon level / MGI
  • abnormal interleukin level / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • decreased susceptibility to weight loss / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).